Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Jun 27:13:905145.
doi: 10.3389/fendo.2022.905145. eCollection 2022.

Editorial: Insights Into Acromegaly Complications

Corin Badiu  1 , Przemyslaw Witek  2
Affiliations
Editorial

Editorial: Insights Into Acromegaly Complications

Corin Badiu et al. Front Endocrinol (Lausanne). .
No abstract available

Keywords: acromegaly arthropathy; diabetes; heart failure; high blood pressure; sleep apnoea.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Comment on

  • Editorial on the Research Topic Insight into Acromegaly Complications

References

    1. Crisafulli S, Luxi N, Sultana J, Fontana A, Spagnolo F, Giuffrida G, et al. . Global Epidemiology of Acromegaly: A Systematic Review and Meta-Analysis. Eur J Endocrinol (2021) 185:251–63. doi: 10.1530/EJE-21-0216 - DOI - PubMed
    1. Scanteie CL, Leucuta DC, Ghervan CMV. Quality of Life in Patients With Acromegaly - A Romanian Single Center Cross-Sectional Study. Acta Endocrinol (Buchar.) (2021) 17:42–50. doi: 10.4183/aeb.2021.4 - DOI - PMC - PubMed
    1. Neggers S, Badiu C, Biagetti B, Durand-Gasselin L, Petit A, Petrossians P, et al. . Pharmacological and Safety Profile of a Prolonged-Release Lanreotide Formulation in Acromegaly. Expert Rev Clin Pharmacol (2021) 14:1551–60. doi: 10.1080/17512433.2021.1986004 - DOI - PubMed
    1. Araujo-Castro M, Pian H, Ruz-Caracuel I, Acitores CA, Pascual-Corrales E, Rodriguez BV. Presurgical Somatostatin Receptor Ligand Treatment Does Not Affect Tumor Consistency in GH-Secreting Pituitary Macroadenomas. Endocr Connect (2021) 10:102–9. doi: 10.1530/EC-20-0414 - DOI - PMC - PubMed

Publication types

LinkOut - more resources